Soundhound AI, Inc. SOUN
14 trading plans running, 23 Form 144 notices for $9.9M
10-Q, 10-K and Form 144What SOUN's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 9, 2026 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| •Michael Zagorsek Chief Operating Officer |
Adopted 10b5-1 plan | Sep 22, 2026 | 10-Q Nov 9, 2026 | ||
What the company wroteMichael Zagorsek, Chief Operating Officer, adopted a new trading plan on September 22, 2026 (with the first trade under the new plan not to be made prior to January 1, 2027). The trading plan will be effective until March 31, 2027 and provides for the sale of up to 1,188,139 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met. | |||||
| •Majid Emami Chief Science Officer and Senior Vice President |
Adopted 10b5-1 plan | Aug 31, 2026 | 10-Q Nov 9, 2026 | ||
What the company wroteMajid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on August 31, 2026 (with the first trade under the new plan not to be made prior to January 1, 2027). The trading plan will be effective until June 30, 2027 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 439,253 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Aug 24, 2026 | 10-Q Nov 9, 2026 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on August 24, 2026 (with the first trade under the new plan not to be made prior to December 1, 2026). The trading plan will be effective until February 28, 2027 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 1,171,059 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Aug 20, 2026 | 10-Q Nov 9, 2026 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on August 20, 2026 (with the first trade under the new plan not to be made prior to January 1, 2027). The trading plan will be effective until March 31, 2027 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 377,527 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Diana Sroka Director |
Adopted 10b5-1 plan | May 28, 2026 | 10-Q Nov 9, 2026 | ||
What the company wroteDiana Sroka, Director, adopted a new trading plan on May 28, 2026 (with the first trade under the new plan not to be made prior to August 27, 2026). The trading plan will be effective until June 30, 2027 and provides for the sale of 7,553 shares of Class A common stock, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | May 28, 2026 | 10-Q Aug 10, 2026 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on May 28, 2026 (with the first trade under the new plan not to be made prior to September 1, 2026). The trading plan will be effective until November 30, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 1,065,848 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •James M. Hom Interim Chief Financial Officer, Chief Product Officer and Director |
Adopted 10b5-1 plan | May 28, 2026 | 10-Q Aug 10, 2026 | ||
What the company wroteJames M. Hom, Interim Chief Financial Officer, Chief Product Officer and Director, adopted a new trading plan on May 28, 2026 (with the first trade under the new plan not to be made prior to October 1, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 322,804 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Mar 10, 2026 | 10-Q May 11, 2026 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on March 10, 2026 (with the first trade under the new plan not to be made prior to June 16, 2026). The trading plan will be effective until August 31, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 1,083,222 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Eric Ball Director |
Adopted 10b5-1 plan | Mar 9, 2026 | 10-Q Aug 10, 2026 | ||
What the company wroteEric Ball, Director, adopted a new trading plan on March 9, 2026 (with the first trade under the new plan not to be made prior to June 8, 2026). The trading plan will be effective until December 31, 2027 and provides for the sale of up to 150,000 shares of Class A common stock, provided that certain conditions are met. | |||||
| •Eric Ball Director |
Adopted 10b5-1 plan | Mar 9, 2026 | 10-Q May 11, 2026 | ||
What the company wroteEric Ball, Director, adopted a new trading plan on March 9, 2026 (with the first trade under the new plan not to be made prior to June 8, 2026). The trading plan will be effective until December 31, 2027 and provides for the sale of up to 150,000 shares of Ms. Sroka's Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Mar 9, 2026 | 10-Q May 11, 2026 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on March 9, 2026 (with the first trade under the new plan not to be made prior to July 1, 2026). The trading plan will be effective until September 30, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 279,479 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Michael Zagorsek Chief Operating Officer |
Adopted 10b5-1 plan | Mar 5, 2026 | 10-Q Aug 10, 2026 | ||
What the company wroteMichael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 5, 2026 (with the first trade under the new plan not to be made prior to July 1, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 179,888 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met. | |||||
| •Michael Zagorsek Chief Operating Officer |
Adopted 10b5-1 plan | Mar 5, 2026 | 10-Q May 11, 2026 | ||
What the company wroteMichael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 5, 2026 (with the first trade under the new plan not to be made prior to July 1, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 179,888 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met. | |||||
| •Majid Emami Chief Science Officer and Senior Vice President |
Adopted 10b5-1 plan | Mar 3, 2026 | 10-Q Aug 10, 2026 | ||
What the company wroteMajid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on March 3, 2026 (with the first trade under the new plan not to be made prior to June 2, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 354,048 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Majid Emami Chief Science Officer and Senior Vice President |
Adopted 10b5-1 plan | Mar 3, 2026 | 10-Q May 11, 2026 | ||
What the company wroteMajid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on March 3, 2026 (with the first trade under the new plan not to be made prior to January 2, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 354,048 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Nov 24, 2025 | 10-K Mar 2, 2026 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on November 24, 2025 (with the first trade under the new plan not to be made prior to March 2, 2026). The trading plan will be effective until June 15, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B Common Stock and up to 931,899 shares of Class A Common Stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Nitesh Sharan Chief Financial Officer |
Adopted 10b5-1 plan | Nov 20, 2025 | 10-K Mar 2, 2026 | ||
What the company wroteNitesh Sharan, Chief Financial Officer, adopted a new trading plan on November 20, 2025 (with the first trade under the new plan not to be made prior to March 2, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 120,000 shares of Class A Common Stock issuable upon exercise of outstanding options and up to 140,754 shares of Class A Common Stock, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Nov 19, 2025 | 10-K Mar 2, 2026 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on November 19, 2025 (with the first trade under the new plan not to be made prior to April 1, 2026). The trading plan will be effective until June 30, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B Common Stock, up to 239,932 shares of Class A Common Stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Majid Emami Chief Science Officer and Senior Vice President |
Adopted 10b5-1 plan | Sep 23, 2025 | 10-Q Nov 10, 2025 | ||
What the company wroteMajid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on September 23, 2025 (with the first trade under the new plan not to be made prior to January 2, 2026). The trading plan will be effective until March 31, 2026 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 301,297 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Aug 19, 2025 | 10-Q Nov 10, 2025 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on August 19, 2025 (with the first trade under the new plan not to be made prior to December 1, 2025). The trading plan will be effective until February 28, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 904,045 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Aug 19, 2025 | 10-Q Nov 10, 2025 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on August 19, 2025 (with the first trade under the new plan not to be made prior to January 2, 2026). The trading plan will be effective until March 31, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 159,879 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Diana Sroka Director |
Adopted 10b5-1 plan | Aug 12, 2025 | 10-Q Nov 10, 2025 | ||
What the company wroteDiana Sroka, Director, adopted a new trading plan on August 12, 2025 (with the first trade under the new plan not to be made prior to November 11, 2025). The trading plan will be effective until May 31, 2026 and provides for the sale of up to 5,370 shares of Ms. Sroka's Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | May 16, 2025 | 10-Q Aug 11, 2025 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on May 16, 2025 (with the first trade under the new plan not to be made prior to August 15, 2025). The trading plan will be effective until November 30, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 728,124 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Michael Zagorsek Chief Operating Officer |
Adopted 10b5-1 plan | Mar 24, 2025 | 10-Q May 12, 2025 | ||
What the company wroteMichael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 24, 2025 (with the first trade under the new plan not to be made prior to June 23, 2025). The trading plan will be effective until June 30, 2026 and provides for the sale of up to 179,888 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Mar 19, 2025 | 10-Q May 12, 2025 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on March 19, 2025 (with the first trade under the new plan not to be made prior to July 1, 2025). The trading plan will be effective until September 30, 2025 and provides for the sale of up to 800,000 shares of Mr. Hom’s 1,812,588 shares of Class B common stock and up to 3,815 shares of Class A common stock, and up to 69,686 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Mar 17, 2025 | 10-Q May 12, 2025 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on March 17, 2025 (with the first trade under the new plan not to be made prior to June 16, 2025). The trading plan will be effective until August 14, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock, up to 737,500 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Majid Emami Chief Science Officer and Senior Vice President |
Adopted 10b5-1 plan | Mar 11, 2025 | 10-Q May 12, 2025 | ||
What the company wroteMajid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on March 11, 2025 (with the first trade under the new plan not to be made prior to June 10, 2025). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock, up to 562,850 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Timothy Stonehocker Chief Technology Officer |
Adopted 10b5-1 plan | Dec 23, 2024 | 10-K Mar 11, 2025 | ||
What the company wroteTimothy Stonehocker, Chief Technology Officer, adopted a new trading plan on December 23, 2024 (with the first trade under the new plan not to be made prior to March 24, 2025). The trading plan will be effective until February 15, 2026 and provides for the sale of up to 395,737 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Eric Ball Director |
Adopted 10b5-1 plan | Dec 20, 2024 | 10-K Mar 11, 2025 | ||
What the company wroteEric Ball, Director, adopted a new trading plan on December 20, 2024 (with the first trade under the new plan not to be made prior to March 21, 2025). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 150,000 shares of Class A common stock, provided that certain conditions are met. | |||||
| •Nitesh Sharan Chief Financial Officer |
Adopted 10b5-1 plan | Dec 13, 2024 | 10-K Mar 11, 2025 | ||
What the company wroteNitesh Sharan, Chief Financial Officer, adopted a new trading plan on December 13, 2024 (with the first trade under the new plan not to be made prior to March 14, 2025). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 120,000 shares of Class A common stock issuable upon exercise of outstanding options and up to 121,506 shares of Class A common stock, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Nov 27, 2024 | 10-K Mar 11, 2025 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on November 27, 2024 (with the first trade under the new plan not to be made prior to March 1, 2025). The trading plan will be effective until June 15, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 737,500 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Nov 27, 2024 | 10-K Mar 11, 2025 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on November 27, 2024 (with the first trade under the new plan not to be made prior to April 1, 2025). The trading plan will be effective until June 30, 2025 and provides for the sale of up to 200,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock, up to 3,815 shares of Class A common stock, and up to 29,534 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Aug 30, 2024 | 10-Q Nov 12, 2024 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on August 30, 2024 (with the first trade under the new plan not to be made prior to December 1, 2024). The trading plan will be effective until February 28, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock, up to 461,026 shares of Class A common stock issuable upon exercise of outstanding options, and up to 461,026 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •Majid Emami Chief Science Officer and Senior Vice President |
Adopted 10b5-1 plan | Aug 28, 2024 | 10-Q Nov 12, 2024 | ||
What the company wroteMajid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on August 28, 2024 (with the first trade under the new plan not to be made prior to December 1, 2024). The trading plan will be effective until May 31, 2025 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock, up to 666,748 shares of Class A common stock issuable upon exercise of outstanding options, and up to 254,067 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Aug 26, 2024 | 10-Q Nov 12, 2024 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on August 26, 2024 (with the first trade under the new plan not to be made prior to December 16, 2024). The trading plan will be effective until March 31, 2025 and provides for the sale of up to 400,000 shares of Mr. Hom’s 2,012,588 shares of Class B common stock and up to 191,857 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met | |||||
| •Diana Sroka Director |
Adopted 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 12, 2024 | ||
What the company wroteDiana Sroka, Director, adopted a modified trading plan on August 12, 2024 (with the first trade under the new plan not to be made prior to December 23, 2024). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 9,604 shares of Ms. Sroka's Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met. | |||||
| •Eric Ball Director |
Adopted 10b5-1 plan | Jun 28, 2024 | 10-Q Aug 9, 2024 | ||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | May 31, 2024 | 10-Q Aug 9, 2024 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on May 31, 2024 (with the first trade under the new plan not to be made prior to September 18, 2024). The trading plan will be effective until December 15, 2024 and provides for the sale of up to 200,000 shares of Mr. Hom’s 2,012,588 shares of Class B common stock and up to 83,064 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met | |||||
| •Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Mar 20, 2024 | 10-Q May 10, 2024 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on March 20, 2024 (with the first trade under the new plan not to be made prior to June 19, 2024). The trading plan will be effective until November 30, 2024 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer’s 14,139,064 shares of Class B common stock, up to 833,435 shares of Class A common stock issuable upon exercise of outstanding options, and up to 467,500 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| •James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Mar 19, 2024 | 10-Q May 10, 2024 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on March 19, 2024 (with the first trade under the new plan not to be made prior to June 18, 2024). The trading plan will be effective until September 15, 2024 and provides for the sale of up to 200,000 shares of Mr. Hom’s 2,012,588 shares of Class B common stock and up to 97,706 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met | |||||
| •Michael Zagorsek Chief Operating Officer |
Adopted 10b5-1 plan | Mar 19, 2024 | 10-Q May 10, 2024 | ||
What the company wroteMichael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 19, 2024 (with the first trade under the new plan not to be made prior to June 18, 2024). The trading plan will be effective until January 31, 2026 and provides for the sale of up to 416,719 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met. | |||||
| •Timothy Stonehocker Chief Technology Officer |
Adopted 10b5-1 plan | Mar 6, 2024 | 10-Q May 10, 2024 | ||
What the company wroteTimothy Stonehocker, Chief Technology Officer, adopted a new trading plan on March 6, 2024 (with the first trade under the new plan not to be made prior to June 5, 2024). The trading plan will be effective until August 12, 2024 and provides for the sale of up to 416,000 shares of Class A common stock, provided that certain conditions are met | |||||
| Dr. Keyvan Mohajer Chief Executive Officer and Director |
Adopted 10b5-1 plan | Dec 12, 2023 | 10-K Mar 1, 2024 | ||
What the company wroteDr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on December 12, 2023 (with the first trade under the new plan not to be made prior to March 12, 2024). The trading plan will be effective until June 7, 2024 and provides for the sale of up to 1,800,000 shares of Dr. Mohajer’s 15,439,064 shares of Class B common stock. up to 833,435 shares of Class A common stock issuable upon exercise of outstanding options, and up to 355,000 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
| Dr. Seyed Majid Emami Chief Science Officer and Senior Vice President of Engineering |
Adopted 10b5-1 plan | Dec 8, 2023 | 10-K Mar 1, 2024 | ||
What the company wroteDr. Seyed Majid Emami, Chief Science Officer and Senior Vice President of Engineering, adopted a new trading plan on December 8, 2023 ( with the first trade under the new plan not to be made prior to March 8, 2024). The trading plan will be effective until November 30, 2024 and provides for the sale of up to 1,950,000 shares of Dr. Emami’s 18,033,756 shares of Class B common stock and up to 666,748 shares of Class A common stock issuable upon exercise of outstanding options, provided that certain conditions are met. | |||||
| James M. Hom Chief Product Officer and Director |
Adopted 10b5-1 plan | Dec 8, 2023 | 10-K Mar 1, 2024 | ||
What the company wroteJames M. Hom, Chief Product Officer and Director, adopted a new trading plan on December 8, 2023 ( with the first trade under the new plan not to be made prior to March 8, 2024). The trading plan will be effective until May 31, 2024 and provides for the sale of up to 2,000,000 shares of Mr. Hom’s 4,012,588 shares of Class B common stock and up to 100,000 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. | |||||
Show the other 37 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 12, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Sep 17, 2026 | DIANA SROKA Director |
1,552 | $9K |
| Sep 15, 2026 | ZAGORSEK MICHAEL Officer |
71,113 | $460K |
| Sep 15, 2026 | HOM JAMES MING Officer, Director |
38,730 | $251K |
| Sep 15, 2026 | EMAMI MAJID Officer |
38,730 | $251K |
| Sep 15, 2026 | MOHAJER KEYVAN Officer, Director, 10% Stockholder |
137,290 | $888K |
| Aug 27, 2026 | DIANA SROKA Director |
1,343 | $9K |
| Jun 17, 2026 | ZAGORSEK MICHAEL Officer |
64,994 | $448K |
| Jun 17, 2026 | HOM JAMES MING Officer, Director |
28,843 | $199K |
| Jun 17, 2026 | EMAMI MAJID Officer |
28,843 | $199K |
| Jun 17, 2026 | MOHAJER KEYVAN Officer, Director, 10% Stockholder |
126,540 | $873K |
| Mar 23, 2026 | DIANA SROKA Director |
1,343 | $9K |
| Mar 20, 2026 | ZAGORSEK MICHAEL Officer |
52,968 | $364K |
| Mar 20, 2026 | HOM JAMES MING Officer, Director |
31,019 | $213K |
| Mar 20, 2026 | EMAMI MAJID Officer |
31,019 | $213K |
| Mar 20, 2026 | MOHAJER KEYVAN Officer, Director, 10% Stockholder |
124,510 | $856K |
| Mar 20, 2026 | SHARAN NITESH Officer |
44,027 | $303K |
| Dec 29, 2025 | SEYED MAJID EMAMI Officer, 10% Stockholder |
32,741 | $357K |
| Dec 23, 2025 | DIANA SROKA Director |
1,343 | $15K |
| Dec 22, 2025 | ZAGORSEK MICHAEL Officer |
73,406 | $809K |
| Dec 22, 2025 | HOM JAMES MING Officer, Director |
42,600 | $469K |
| Dec 22, 2025 | EMAMI MAJID Officer |
42,600 | $469K |
| Dec 22, 2025 | MOHAJER KEYVAN Officer, Director, 10% Stockholder |
144,326 | $1.6M |
| Dec 22, 2025 | SHARAN NITESH Officer |
60,780 | $670K |
Show the other 15 notices
From the Form 144 XML filed with the SEC, since Dec 22, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SOUN/export.csv") into a cell.